KIF5B-RET fusions in lung adenocarcinoma

…, I Sekine, S Ogawa, CC Harris, H Tsuda, T Yoshida… - Nature medicine, 2012 - nature.com
We identified in-frame fusion transcripts of KIF5B (the kinesin family 5B gene) and the RET
oncogene, which are present in 1–2% of lung adenocarcinomas (LADCs) from people from …

Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus

…, A Sekine, Y Nakamura, K Yamamoto, T Yoshida… - Nature …, 2008 - nature.com
We carried out a multistage genome-wide association study of type 2 diabetes mellitus in
Japanese individuals, with a total of 1,612 cases and 1,424 controls and 100,000 SNPs. The …

[PDF][PDF] Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer

…, H Kunitoh, T Shibata, T Sakiyama, T Yoshida… - J Clin …, 2005 - mhlw-grants.niph.go.jp
Purpose To evaluate epidermal growth factor receptor (EGFH) mutations and copy number
as predictors of clinical outcome in patients with non-small-cell lung cancer (NSCLC) …

Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

…, T Katagiri, O Ogawa, W Obara, H Ito, T Yoshida… - Nature …, 2020 - nature.com
The overwhelming majority of participants in current genetic studies are of European ancestry.
To elucidate disease biology in the East Asian population, we conducted a genome-wide …

[HTML][HTML] Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer

…, M Hirata, K Sugano, T Yoshida… - … England Journal of …, 2023 - Mass Medical Soc
Background Helicobacter pylori infection is a well-known risk factor for gastric cancer. However,
the contribution of germline pathogenic variants in cancer-predisposing genes and their …

[BOOK][B] Group technology: applications to production management

I Ham, K Hitomi, T Yoshida - 2012 - books.google.com
Mass productio! l and mass consumption, so far considered virtues in a free economic soceity,
have changed. Various problems have occurred including economic stagnation, energy …

High-resolution characterization of a hepatocellular carcinoma genome

…, T Kosuge, T Okusaka, K Kato, J Kusuda, T Yoshida… - Nature …, 2011 - nature.com
Hepatocellular carcinoma, one of the most common virus-associated cancers, is the third most
frequent cause of cancer-related death worldwide 1 . By massively parallel sequencing 2 …

Distinctive expression and function of four GSDM family genes (GSDMA‐D) in normal and malignant upper gastrointestinal epithelium

…, K Ogawa, H Sakamoto, T Yoshida… - Genes …, 2009 - Wiley Online Library
Gasdermin (GSDM or GSDMA), expressed in the upper gastrointestinal tract but frequently
silenced in gastric cancers (GCs), regulates apoptosis of the gastric epithelium. It has three …

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1* 6 and* 28

…, H Ohmatsu, K Kubota, T Yoshida… - Pharmacogenetics …, 2007 - journals.lww.com
Objectives SN-38, an active metabolite of irinotecan, is detoxified by glucuronidation with
UGT1A isoforms, 1A1, 1A7, 1A9, and 1A10. The pharmacogenetic information on UGT1A …

Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: a hospital‐based study

…, M Yoshida, A Yoshida, H Yoshida… - Cancer …, 2019 - Wiley Online Library
Next‐generation sequencing ( NGS ) of tumor tissue (ie, clinical sequencing) can guide
clinical management by providing information about actionable gene aberrations that have …